In honor of our more than 100 nano-rare patients, n-Lorem CEO Stan Crooke threw this ceremonial first pitch ball to Yankees’ 2023 first round draft selection George Lombard Jr. at a New York Yankees / Detroit Tigers Spring Training game on March 3, 2024. Signed by antisense technology pioneer Stan Crooke, the significance of this ball lies in the hope and potential help that n-Lorem provides to nano-rare disease patients and their families. Imagine this baseball in your collection, or the look on a loved one’s face when they receive it. Perfect for Father’s Day!
During Dr. Crooke’s tenure as the former and founding CEO of Ionis Pharmaceuticals, he led the scientific development of a new platform for drug discovery, antisense technology, and the creation of one of the largest and more advanced development pipelines in the biotechnology industry, and commercialized several antisense drugs including, SPINRAZA® (nusinersen), TEGSEDI™ (inotersen) and others. Dr. Crooke has recently been awarded the 2022 Steven C. Beering Award from Indiana University for outstanding research contributions to advancing biomedical or clinical science, and was presented with the 2022 Roy Vagelos Pro Bono Humanum Award for Global Health Equity from the Prix Galien USA for improving the human condition in extraordinary ways.